FDA Adverse Event Malfunction Summary report: N

ACCU-CHEK INFORM II TEST STRIPS

MDR report key: 18168758 · Received November 20, 2023

Report

Report Number
1823260-2023-03674
Event Type
Malfunction
Date Received
November 20, 2023
Date of Event
October 25, 2023
Report Date
December 21, 2023
Manufacturer
ROCHE DIAGNOSTICS
Product Code
LFR
UDI-DI
00365702428102
PMA / PMN Number
K121679
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

NO PRODUCT IS EXPECTED TO BE RETURNED. NO INFORMATION WAS PROVIDED THAT WOULD POINT TO A CAUSE FOR THE DISCREPANCY IN RESULTS. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM.

Additional Manufacturer Narrative · 0

THE ACCU-CHEK INFORM II STRIPS' EXPIRATION DATE WAS NOT PROVIDED. THE ACCU-CHEK INFORM II METER SERIAL NUMBER WAS (B)(6). THE STRIPS WERE REQUESTED FOR INVESTIGATION. ON A REGULAR BASIS, ACCU-CHEK INFORM STRIPS OF LOTS CURRENTLY VALID IN THE MARKET ARE TESTED AS PART OF ROUTINE RETENTION TESTING AND RESULTS HAVE PASSED THE INTERNAL INSPECTION.

Description of Event or Problem · 0

THE REPORTER COMPLAINED OF DISCREPANT GLUCOSE RESULTS FOR 1 PATIENT'S SAMPLE TESTED ON ACCU-CHEK INFORM II METER. INITIAL RESULT: 42 MG/DL (TESTED AT 9:55 AM). 1ST REPEAT RESULT: 93 MG/DL (TESTED AT 9:58 AM). 2ND REPEAT RESULT: 109 MG/DL (TESTED AT 9:59 AM). THE REPORTER CONFIRMED THAT QCS WERE PERFORMED DAILY AND THEY PASSED. THE MEDICAL STAFF BELIEVED THAT EITHER 109 MG/DL OR 93 MG/DL WERE CORRECT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1599799 ACCU-CHEK INFORM II TEST STRIPS BLOOD GLUCOSE MONITORING TEST STRIPS LFR ROCHE DIAGNOSTICS 670233 00365702428102

Patients

Seq Age Sex Outcome Treatment
1 19 YR Female CHLORHEXIDINE| EESAZOLIN| SODIUM ACETATE TRIHYDRATE| TYLENOL 650 MG